TrialMedical oncology (Northwood, London, England)2017

Fluorescence in situ hybridization as prognostic predictor of tumor recurrence during treatment with Bacillus Calmette-Guérin therapy for intermediate- and high-risk non-muscle-invasive bladder cancer.

Esmee I M L Liem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.